The estimated association between Helicobacter pylori and Barrett ' s esophagus (BE) has been heterogenous across previous studies. In this study, we aimed to examine the association between H. pylori and BE and to identify factors that may explain or modify this association.
INTRODUCTION
Esophageal adenocarcinoma is a highly fatal disease ( 1 ) . In developed countries including the United States, the incidence of esophageal adenocarcinoma has increased in recent years for all races, but especially in non-Hispanic White men ( 2,3 ). Barrett ' s esophagus (BE) is a precancerous lesion for esophageal adenocarcinoma ( 4, 5 ) but the causal process leading to BE has yet to be elucidated.
Helicobacter pylori , a bacterial infection that colonizes the human gastric mucosa, modulates gastric acid production, which may aff ect the development of refl ux esophagitis, BE, and ultimately esophageal adenocarcinoma ( 6 -10 ) . H. pylori , which causes gastric infl ammation and atrophy, may in some patients lower acid production in the stomach by damaging the acid-producing parietal cells in the corpus ( 11 ) . Evidence from meta-analyses and systematic reviews examining the association between H. pylori and gastroesophageal refl ux disease have tended to show an inverse association, although this association has been shown to be heterogeneous across studies ( 12 -14 ) . Similarly, meta-analyses examining the association between H. pylori and BE have shown heterogenous fi ndings across studies ( 15 -17 ) . Th ere is a paucity of evidence evaluating whether histological changes such as corpus gastritis or atrophy and other factors related to gastric acidity could be a source of this heterogeneity.
Th erefore, we conducted a case -control study that aimed to examine the association between H. pylori and BE using an identifi able base population seeking healthcare within the veterans aff airs (VAs) system in Houston, TX. We also aimed to examine whether factors such as histological changes in the stomach or gastroesophageal refl ux disease symptoms could explain this association, and whether corpus gastritis, corpus atrophy, and / or antisecretory medication could modify this association. Cases were those aged 50 -80 diagnosed with BE in this VA system, and our primary control group came from individuals from primary care who were eligible (aged 50 -80) for a screening colonoscopy in this same VA system. We characterized the extent and severity of gastritis and gastric atrophy by performing systematic gastric mapping biopsies for cases and controls.
METHODS

Study design and study population
To obtain the cases and controls for this study, we fi rst recruited subjects aged 50 years and above seeking healthcare at the Michael E DeBakey Veterans Aff airs Medical Center (MED-VAMC) in Houston, TX from 1 September 2008 to 31 December 2011. We recruited subjects from consecutive patients identifi ed at primary care facilities in the MEDVAMC system who were eligible for a routine screening colonoscopy and agreed to also undergo an esophagogastroduodenoscopy (EGD) along with their colonoscopy. Our secondary recruitment source was consecutive eligible patients undergoing an elective EGD. We performed gastric mapping by taking seven mucosal biopsy samples from the antrum (from the greater curvature and from the lesser curvature), the corpus (from the distal greater curvature, distal lesser curvature, proximal greater curvature, proximal lesser curvature), and the cardia. Live-case orientation sessions were conducted with the endoscopists to demonstrate landmarks, biopsy sites, and recorded fi ndings regarding suspected BE.
Th is study was approved by the Institutional Review Boards at both the MEDVAMC and Baylor College of Medicine.
Eligibility criteria for cases and controls
We took at least one biopsy sample from subjects with suspected BE at the site where columnar-appearing mucosa was visually observed between the gastroesophageal junction and the Z-line. We used the Prague CM classifi cation to measure the height of circumferential columnar mucosa in centimeters above the gastroesophageal junction (the C value) and the maximum length in centimeters of the columnar mucosa above the gastroesophageal junction (the M value) ( 18 ) . Cases with BE were subjects from the EGD patient group or the screening colonoscopy group who met our eligibility criteria and had intestinal metaplasia confi rmed by two pathologists (MR and GV) in their histopathological examination of the biopsy tissue taken at the site where suspected BE was found. Th ese BE assessments were performed blind to the subjects ' H. pylori status.
We were not able to sample from all primary care patients because of the large number of patients seen at the MEDVAMC. Th erefore, we recruited subjects from seven participating primary care clinics who were eligible for a screening colonoscopy for our " screening colonoscopy " control group. We screened electronic medical records for all patients scheduled for an appointment with their primary care provider to determine eligibility for screening colonoscopy (aged 50 -80 and no colonoscopy in the previous 3 years) and invited them to undergo an EGD along with their colonoscopy. Endoscopy controls included all consecutive endoscopy controls scheduled for elective upper endoscopy who met our inclusion criteria, and agreed to participate in the study but were not diagnosed with BE.
Between 1 September 2008 and 31 December 2011, all cases and controls met the inclusion criteria of (1) being 50 -80 years of age; (2) completing an EGD examination with gastric mapping biopsies; and (3) provided informed consent. In addition, none of the eligible subjects had any of the following exclusion criteria: (1) previous gastroesophageal surgery; (2) previous esophageal, lung, liver, colon, breast, or stomach cancer; (3) current use of anticoagulants; (4) platelet counts < 70,000, ascites, or known gastroesophageal varices; or (5) history of major stroke or a mental condition that could inhibit our ability to obtain valid information from the interview. Subjects in the controls groups were also excluded if they were diagnosed with defi nitive or suspected BE during the study EGD examination.
Measurement of H. pylori , gastritis, and atrophy
Biopsy specimens were stained with: (1) hematoxylin and eosin; (2) a modifi ed silver stain; and (3) an alcian blue-Periodic acid Schiff stain to detect prevalent H. pylori infection. In all cases where there was a low density of silver-stained organisms, their identity was confi rmed by immunohistochemical staining. Biopsies were examined and graded by two gastrointestinal pathologists (MR and GV). Features of gastritis and gastric atrophy were identifi ed and graded according to the standardized operative link for gastritis assessment system ( 19 ) , which uses the updated Sydney System ( 20 ) . Prevalent H. pylori status was determined blind to the subjects ' BE diagnosis and was classifi ed as positive if the organism was histologically observed in any of the gastric biopsies.
As part of our sensitivity analyses, we randomly selected 285 (60 % ) subjects classifi ed as H. pylori negative by histology in the primary analysis for further culture of their gastric samples. Frozen specimens were thawed and the tissue was homogenized and inoculated onto two types of selective media, Brain Heart Infusion and H. pylori Special Peptone Agar plates with 7 % horse blood. Th e plates were incubated at 37 ° C under microaerophilic conditions. Th e negative plates were reincubated and then read every 24 h for up to 14 days. Positive growth was transferred to a fresh, nonselective Brain Heart Infusion blood agar plate, and then incubated for 48 -72 h. H. pylori was identifi ed by culture when the oxidase, catalase, and urease reactions were positive with a compatible Gramnegative stain. A subject was considered defi nitively positive for H. pylori if H. pylori was identifi ed as positive either by histology or culture.
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Measurement of other covariates
We interviewed all study participants before the EGD to collect data on relevant covariates such as age, gender, race, the onset, frequency, and severity of symptoms of gastroesophageal refl ux disease using the Gastroesophageal Refl ux Questionnaire ( 21 ), current and previous smoking status, dietary intake, and frequency of medication use such as proton pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs). Th e frequency of dietary intake of fruits and vegetables was obtained using the Block Food Frequency Questionnaire ( 22 ) . Height and weight was also measured before endoscopy to determine the body mass index.
Analysis
We fi rst performed descriptive analyses for the study population using χ 2 -tests to compare the cases and screening colonoscopy controls with regard to demographic variables, smoking, obesity, symptoms, medication use, and histological factors. For the primary analysis, we compared cases and screening colonoscopy controls using logistic regression to obtain odds ratios (ORs) and 95 % confi dence intervals (CIs) to estimate the association between H. pylori and BE while controlling for age and non-Hispanic white race as potential confounders. Further adjustment for black race, gender, obesity, smoking, nonsteroidal anti-infl ammatory medications, and dietary factors were controlled for if they changed the estimates by > 10 % ( 23 ) . In addition, we used logistic regression models to estimate the association between histological changes in the stomach and BE. We then examined whether histological changes in the stomach and / or gastroesophageal refl ux disease symptoms could explain the association between H. pylori and BE by adding these variables to the model containing H. pylori . We also examined whether factors that aff ect gastric-acid secretion such as corpus gastritis, corpus atrophy, and / or antisecretory medication could modify the association between H. pylori and BE by using stratifi ed logistic regression models, likelihood ratio tests in nested models, and linear binomial regression to assess additive interaction while adjusting for confounders. As our analyses focused on achieving our study aims, no multiple comparison adjustments were made, as others have discussed in detail elsewhere that such adjustment is not relevant and would produce inappropriately imprecise estimates ( 24, 25 ) . Th e analyses were also conducted for short-segment and long-segment BE separately. Cases with BE whose C value or M value was ≥ 3 were classifi ed as long-segment BE, whereas those whose C-value and M-value was < 3 were classifi ed as short-segment BE ( 26 ) .
We conducted sensitivity analyses to evaluate the robustness of our estimates. As mentioned previously, bacterial culture of gastric samples was performed in randomly selected subjects classifi ed as H. pylori negative based on histology. Additional sensitivity analyses were performed using a control group from the cross-sectional study of endoscopy patients without BE ( ' upper endoscopy control group ' ) who met the eligibility criteria. As patients referred for an upper endoscopy may recall information (for example, medication use, dietary information, and symptoms) diff erently than participants from the screening colonoscopy group, we compared the estimated association using the screening colonoscopy controls with the estimated association using the upper endoscopy controls.
RESULTS
We identified 218 eligible cases with BE; 133 (61.0 % ) were classified as short-segment BE and 85 (39.0 % ) were classified as long-segment BE. Out of 1,424 patients who were invited to also undergo an EGD along with their screening colonoscopy, 380 did not fulfill our eligibility criteria, 287 refused to participate, and 318 did not show up for their EGD appointment. Therefore, 42 % (439 participants) of the 1,044 eligible screening colonoscopy controls whom we invited to participate were enrolled in our study. The cases and controls are descriptively compared in Tables 1A and B . The vast majority of participants were men for both cases and controls, which was expected in this VA population (97.3 % for cases and 96.6 % for controls). Overall, the study population consisted of 66.4 % non-Hispanic white participants; there were more non-Hispanic white participants in the case group (87.2 % ) compared with the controls (56.0 % ), and thus more African Americans among the controls (41.7 % ) compared with cases (11.9 % ). Approximately half of all cases (51.4 % ) and controls (47.8 % ) were obese. Most cases and controls were either current smokers (23 % and 25 % , respectively) or former smokers (46.5 and 48.3 % , respectively). Cases were more likely to report frequent symptoms ( > 1 times per week) of heartburn and acid regurgitation compared with controls (35.8 vs. 20.1 % ). Similarly, cases were more likely to report frequently taking ( > 1 times per week) PPIs (71.3 vs. 22.8 % ) and H2RAs (10.5 vs. 5.5 % ) compared with controls.
H. pylori infection was identifi ed in 16.1 % of cases and 33.3 % of controls ( P < 0.0001). Only 2 of 181 (1.1 % ) H. pylori -positive subjects whose biopsies were cultured were positive using culture alone. We compared the gastric histological features of cases and controls ( Table 1B ) . Th e proportions of subjects with gastritis are those of the total population and not of the H. pylori -positive subjects. Corpus gastritis was consistently present less frequently among cases compared with controls (17.9 vs. 32.4 % ); this diff erence was mostly explained by diff erence in severe corpus gastritis (14.7 vs. 27.1 % ). Gastritis was only observed more frequently (although not signifi cantly more) among cases vs. controls for grade 1 antral gastritis and gastritis, which was exclusively found in the antrum. Atrophy was observed less frequently among the cases with BE compared with the controls (18.4 vs. 28.7 % ). Similarly, corpus atrophy was less frequently observed in cases vs. controls (11.5 vs. 18.7 % ).
Results of our overall logistic regression analyses yielded an OR showing H. pylori to be inversely associated with BE aft er controlling for age and non-Hispanic white race (OR: 0.55; 95 % CI: 0.35 -0.84) ( Table 2 ) . Th e addition of black race to the model did not alter the OR estimate (OR: 0.55; 95 % CI: 0.35 -0.85). Other variables also did not substantially change the OR estimate ( Table 2 ) . Th erefore, all subsequent models contained age and non-Hispanic white race. In sensitivity analyses, similar results were obtained using endoscopy controls ( Table 2 ). Only two ( < 1 % ) subjects who were classifi ed as H. pylori negative based on histology and who had further bacterial culture results were identifi ed as positive for H. pylori using culture. Our results were similar for analyses that included histology alone vs. histology and available culture results. Th erefore, unless specifi ed otherwise, we The estimates were generated from logistic regression models comparing BE cases ( N =218) to either screening colonoscopy controls or endoscopy controls. All cases and controls underwent study esophagogastroduodenoscopy. Non-Hispanic white race.
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Association Between H. pylori and BE slightly stronger inverse association was observed for long-segment BE ( BE, Barrett's esophagus; CI, confi dence interval; N , number of subjects; OR, odds ratio. The estimates are calculated using separate logistic models comparing BE cases to screening colonoscopy controls ( N =439). All models include (control for) age and non-Hispanic white race, and screening colonoscopy controls were used .
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changes in the stomach and BE, we observed that these tended to show stronger inverse associations between the histological change and long-segment BE compared with short-segment BE ( Table 3 ) . Th e OR for the estimated association between corpus gastritis and BE was 0.42 (95 % CI: 0.21 -0.86) and 0.82 (95 % CI: 0.50 -1.32) for long-segment and short-segment BE, respectively. Similar associations were observed for antral active and chronic gastritis. Similarly, the OR for the estimated association between any atrophy and BE was 0.65 (95 % CI: 0.34 -1.26) and 0.86 (95 % CI: 0.52 -1.26) for long-and short-segment BE, respectively. We added to the model putative intermediates in the causal pathway whereby H. pylori may aff ect BE to evaluate whether they could attenuate and hence explain the inverse association between H. pylori and BE ( Table 4 ). When gastritis, especially corpus gastritis, was added to the model, the OR for the association between H. pylori and BE was attenuated to 0.79 (95 % CI: 0.47 -1.31). Table 5 , Appendices Tables A1 -G1 and A2 -G2 present the results of our analyses of eff ect modifi cation. When we estimated the adjusted ORs by PPI or H2RA use, we observed an inverse but nonsignifi cant association between H. pylori and BE among those using a PPI or H2RA ≥ 1 times per week (OR: 0.56; 95 % CI: 0.27, 1.14), and did not observe a strong inverse association among those who were not taking these medication or taking them less than weekly (OR: 0.90; 95 % CI: 0.49, 1.66). When we stratifi ed the adjusted OR separately by corpus atrophy or corpus gastritis, we did not observe obvious eff ect modifi cation using a multiplicative model. However, when we stratifi ed the OR by corpus atrophy or antisecretory drug use ( ≥ 1 time per week), we observed a strong inverse association between H. pylori and BE among those with corpus atrophy or antisecretory use (OR: 0.28; 95 % CI: 0.15, 0.50) and did not observe an inverse association between H. pylori and BE in the strata without these factors (OR: 1.32; 95 % CI: 0.66, 2.63); likelihood ratio tests suggested multiplicative interaction ( P = 0.0006) in nested models. We did not observe additive interaction between H. pylori and either corpus gastritis or corpus atrophy separately or in combination ( Appendices Tables B2,C2 and F2 ). However, we did observe additive interaction between H. pylori and the use of antisecretory medication in unadjusted models, and between H. pylori and corpus, atrophy or antisecretory drugs in unadjusted and adjusted models ( Appendices Tables A2 and D2 ).
DISCUSSION
Overall, our results are consistent with the hypothesis that being infected with H. pylori is inversely associated with BE. Even aft er controlling for potential confounding by age and non-Hispanic White race, we estimated that the odds of observing prevalent H. pylori was approximately half among cases with BE compared with controls without BE. Th e overall inverse association between H. pylori and BE was observed in both control groups (screening colonoscopy or upper endoscopy controls) and with either long-segment or short-segment BE as the outcome. Our current fi ndings add to the existing examination of the association between H. pylori and BE, and the evaluation of whether histological and other factors related to gastric acidity could explain or modify the association between H. pylori and BE. As described in previous meta-analyses, previous studies have reported heterogenous fi ndings ( 15 -17 ) . In the meta-analysis by Wang et al. ( 16 ) , signifi cant heterogeneity in the association of H. pylori and BE was also observed across studies, and this heterogeneity was explained by the type of controls selected and the location of the study being conducted in Asia. We also observed in our recent meta-analysis that, because of the manner in which the non-BE controls were selected, most existing studies examining the association between H. pylori and BE had potential sources of selection bias ( 15 ) . Th erefore, we selected controls from subjects who were eligible for a screening colonoscopy to estimate subjects who if they were to have BE would be diagnosed with BE in this same VA base population. However, in the current investigation, no obvious selection bias was observed for the endoscopy controls, as the results for both types of control groups were similar. Nevertheless, our results are similar to results from four studies identifi ed in our meta-analysis with identifi able base populations that also used gastric tissue to diagnose H. pylori ( 15 ) , and with recent fi ndings from a case -control study by Rubenstein et al. ( 33 ) using colorectal cancer screening controls in Michigan. Th e OR estimate overall from the Michigan study was 0.53 (95 % CI: 0.29 -0.97) compared with 0.55 (95 % CI: 0.35 -0.84) in our study. Th e study by Rubenstein et al. ( 33 ) also reported an even stronger inverse association between CagA-positive strains of H. pylori and BE (0.36; 95 % CI: 0.14 -0.90).
Although the current study was designed to minimize potential biases such as selection bias and confounding, selection bias in the form of self-selection bias could have occurred as only 42 % of the eligible screening colonoscopy controls whom we invited to participate actually enrolled in our study. If correlates of H. pylori infection, such as socioeconomic status, infl uenced participation in the study diff erently for cases and controls, then this could have led to selection bias.
As we have already discussed, our study limitations also include potential misclassifi cation of H. pylori in the presence of PPI use and advancing atrophic gastritis. Even aft er controlling for age and non-Hispanic white race, residual confounding may have occurred for potential confounding factors such as fruit and vegetable intake. Data regarding the intake of fruits and vegetables were missing for 42 % of the subjects, and therefore this variable was not controlled for in our primary analyses. However, the estimated association between H. pylori and BE However, the strong inverse association between H. pylori and BE was restricted to patients with corpus atrophy or to those who had regularly taken antisecretory medications, which would likely suppress gastric acid secretion.
We also observed that the presence of corpus gastritis was inversely associated with the presence of BE. Corpus gastritis also partially explained the association between H. pylori and BE. Th ese fi ndings are consistent with other evidence showing H. pylori infection causes infl ammation in the stomach, which could inhibit acid production in the corpus of the stomach ( 11, 27 ) . Lower acid production in the stomach would decrease the likelihood of damaging acid refl ux into the esophagus, thus leading to protective eff ects on disease outcomes in the esophagus. Th ere was a strong association between the presence of corpus gastritis and that of antral gastritis, and therefore we observed similar associations between antral gastritis and BE, and gastritis overall and BE. We also observed a strong association between H. pylori infection and corpus gastritis, which resulted in small cell sizes in stratifi ed analyses involving these variables. For example, only 11 subjects (2 cases and 9 controls) without corpus gastritis were infected with H. pylori , which resulted in unstable estimates in the assessment of eff ect modifi cation involving corpus gastritis ( Appendices Tables C1, E1 -G1 ) .
Corpus atrophy may also damage the acid-producing parietal cells that could reduce acid exposure to the esophagus, and therefore this variable would also be expected to attenuate the association between H. pylori and BE ( 28 ) . However, we did not observe attenuation of the association between H. pylori and BE by corpus atrophy. One reason we may not have been able to observe attenuation of H. pylori on BE by corpus atrophy may be owing to misclassifi cation of atrophic gastritis because of its patchy distribution ( 29 ) . Although intestinal metaplasia may provide a better measure of glandular loss, we also did not observe attenuation of the H. pylori -BE association by intestinal metaplasia. Both advancing atrophic gastritis and intestinal metaplasia may lead to the disappearance of H. pylori ( 30 ) , which may have compromised our ability to observe these lesions as intermediate factors infl uencing the association between H. pylori and BE. Furthermore, the cross-sectional nature of the current study with prevalent H. pylori and prevalent histological variables prevented an examination of the temporal relation between H. pylori infection, possible intermediate or modifying factors and BE.
Corpus atrophy or frequent use of a PPI or an H2RA modifi ed the association between H. pylori and BE. Th ese fi ndings could suggest that the existence of corpus atrophy or use of acid-suppressive medication potentiates the protective eff ect of H. pylori on BE. However, we also observed that H. pylori infection was more likely to be detected among participants who were not taking a PPI compared with those who were (34.1 % vs. 15.3 % ). Previous studies have observed that PPIs can suppress H. pylori infection, leading to misclassifying H. pylori as absent when it is present ( 31 ) . However, we used multiple samples from both the antrum and the corpus to detect H. pylori, which would have minimized such misclassifi cation ( 32 ) . We also used gastric tissue culture to test for was similar with or without the inclusion of fruit and vegetable intake in the model (OR: 0.55 without fruit and vegetable intake, and OR: 0.52 with fruit and vegetable intake), and therefore it is unlikely fruit and vegetable intake confounded the estimates in our study.
Our study is also limited by the measurement of prevalent H. pylori . Th erefore, we do not know whether H. pylori aff ects the occurrence of BE or vice versa . However, as H. pylori infection is primarily initially acquired during childhood ( 34 ) , it is more likely that H. pylori infection preceded BE.
Finally, our study was conducted in a study population aged 50 -80 years from the MEDVAMC in Houston TX, which consisted primarily of males, and therefore our results are not generalizable to females, or patients under age 50. In addition, our study population was more likely to smoke, be obese, and was slightly more likely to be white non-Hispanic (66.4 % ) as compared with the general population of the United States ( 35 ) , which further limits the generalizability of our fi ndings.
Conclusion
Overall, we observed that the presence of H. pylori was inversely associated with BE in a primarily male population, and this inverse association was observed to be restricted to subjects who have characteristics that lower gastric-acid production such as corpus atrophy or use of antisecretory medication on a weekly basis. Th e odds of BE was estimated to be approximately half as much among H. pylori -infected individuals compared with those without H. pylori infection. 
